Estimates of Savings in Clinical Care in Canada by Managing Elevations in Blood Cholesterol Levels (? 6.2 mmol/L) using Functional Foods with Nutraceuticals rather than Pharmaceuticals for Lipid-Lowering - PowerPoint PPT Presentation

1 / 23
About This Presentation
Title:

Estimates of Savings in Clinical Care in Canada by Managing Elevations in Blood Cholesterol Levels (? 6.2 mmol/L) using Functional Foods with Nutraceuticals rather than Pharmaceuticals for Lipid-Lowering

Description:

Boom to Canadian economy/production of products, job creation, reduced ... Functional foods need to become the pharmacy' for disease prevention as well as management. ... – PowerPoint PPT presentation

Number of Views:84
Avg rating:3.0/5.0

less

Transcript and Presenter's Notes

Title: Estimates of Savings in Clinical Care in Canada by Managing Elevations in Blood Cholesterol Levels (? 6.2 mmol/L) using Functional Foods with Nutraceuticals rather than Pharmaceuticals for Lipid-Lowering


1
Use of Natural Products Including Omega-3 Fatty
Acids for Preventive Health Care and for Lowering
Health Care Costs Prof. Bruce J.
Holub Department of Human Biology Nutritional
Sciences University of Guelph Guelph, ON, Canada
Conference on Seal Oil, Collagen, and Protein
Products June 7-8th, 2004 - DFAIT, Ottawa
2
Nutraceuticals and functional foods can be
defined as follows by Health Canada A
nutraceutical is a product isolated or purified
from foods that is generally sold in medicinal
forms not usually associated with food. A
nutraceutical is demonstrated to have a
physiological benefit or provide protection
against chronic disease (Health Canada). A
functional food is similar in appearance to, or
may be, a conventional food, is consumed as part
of a usual diet, and is demonstrated to have
physiological benefits and/or reduce the risk of
chronic disease beyond basic nutritional
functions (Health Canada).  
3
The above definitions for nutraceuticals and
functional foods, while helpful, fail to
appreciate and allow for the important roles that
these can also play in retarding disease
progression, enhancing disease management, and
offering effective risk factor modification in
those with existing disease (as most Canadians
have by their fifties).
4
Nutraceuticals Functional Foods Wellness
Foods Medicinal Foods Pharma Foods
5
Estimated Prevalence of Cardiovascular Disease
in Americans by Age and Sex
Percent of Population
Age (yr)
Sourcehttp//www.americanheart.org
6
Partial Listing of Lifestyle-related and other
Disorders/Diseases where Nutraceuticals/Functional
Foods can play a Major Role in
Prevention/Management
  1. Cardiovascular Diseases (CVD) and risk factors
    (blood lipids, b.p., etc.)
  2. Type 2 Diabetes
  3. Cancers (colon, prostate, breast, others)
  4. Osteoporosis
  5. Kidney Disorders
  6. Inflammatory conditions (arthritis, bowel, etc.)
  7. Psychiatric disorders
  8. Others

7
Health Care Expenditure in Canada
Parameter billion/yr
Cardiovascular Cancer Type 2 Diabetes Arthritis Drugs Diet-related Disorders Total 13 20 10 10 15 30 gt 100
8
  • Selected Rationale for Introduction of Functional
    Foods into Marketplace and Health-Care System
  • Current Canadian health policy of medical
    treatment (pharmaceuticals, etc.) with or without
    dietary advice denies public the benefit offered
    by nutraceuticals/functional foods.
  • Most Canadians refuse to follow Health Canadas
    Guidelines for Healthy Eating (reluctance to
    change from Western-style diet).
  • Current dietary patterns/foods in Canada dont
    provide sufficient intakes of natural
    nutraceutical components needed for optimal
    health promotion or disease prevention/management.

9
  1. Lifestyle (diet)related chronic
    diseases/disorders in Canada are major burden on
    health care costs (particularly with ageing
    population).
  2. Offers low-cost and early control of risk factors
    for subsequent disease (e.g., heart disease).
  3. Offers a preventive model for disease
    prevention rather than the current medical
    model.
  4. Dietary advice often proven to be ineffective on
    longer-term (e.g., blood cholesterol-lowering by
    dietary advice).
  5. Offers control of moderately elevated risk
    factors (e.g., blood cholesterol, triglyceride,
    etc.) which current health-care system fails to
    control.

10
  1. High quit rate on pharmaceutical agents.
  2. Functional foods can serve as optional or
    complementary approaches for risk factor control
    and disease management (not offered to Canadians
    today despite clinical/scientific evidence).
  3. Other countries (physicians, etc.) routinely use
    nutraceutical/functional foods for health care.
  4. Dramatic reduction in health care costs.
  5. Boom to Canadian economy/production of products,
    job creation, reduced dependency on
    imported/costly pharmaceutical products, etc.
  6. Others

11
Paradigm Shift in Health Care is Needed in
Canada Current Medical Model (later in life)
Medical Management with or without Dietary
Advice of Chronic Disorders/Diseases (no
Functional Foods/Nutraceuticals Future
Preventive Model (early in life) Wide
introduction and use of Functional
Foods/Nutraceuticals for Prevention of Chronic
Disorders/Diseases
12
.
(50 eligible for drug therapy) ( 40 have
CVD) (lt 10 eligible for drug therapy) (lt5 have
CVD)
(drug therapy)
(current)
(future if FFoods)
Ages
13
Blood Plasma Triglyceride Levels (mmol/L) in the
Population (45-54 yr)
50
lt1.1
Percentage of Population
25
1.1-2.2
gt2.3
0
No-Low Risk
Moderate-High Risk No Clinical Management
High Risk Candidates for Clinical Management
14
Effects of Selenium Supplementation for Cancer
Prevention in Patients with Carcinoma of the Skin
A Randomized Controlled Trial
(Clark et al. JAMA. 19962761957-1963)
15
Reduction in Cancer
Total cancer incidence Total cancer mortality Prostate cancer incidence Colorectal cancer incidence 37 50 65 61
200 ug Selenium/day as nutraceutical
supplementation
16
Some Examples of Natural Blood Triglyceride-Loweri
ng Nutraceutical Ingredients and their Potential
to Reduce Subsequent Heart Disease Treatment
Costs if Initiated as Preventive Foods in Healthy
Individuals
Nutraceutical Ingredient Wholesale Cost of Daily Ingredient to Lower Triglyceride (by 8) Expected Decrease in Disease Risk Reduced Expenditure for Heart Disease per year
Omega-3 Fatty Acids (EPA/DHA) 13 cents/day (yearly cost 47) 20 (in women) 7.5 (in men) 2.70 billion (both genders)
Includes both reduced dependency on costly
triglyceride-lowering drugs later life and the
reduced risk for later disease development
needing costly medical treatment. Expected
decrease () in disease risk based on published
literature giving blood lipid changes in relation
to disease risk. Higher intakes of nutraceutical
ingredients in functional foods will give a
corresponding lower decrease in later disease and
greater cost savings.
17
Potential Savings with Nutraceuticals/Functional
Foods
  1. Via Disease Prevention 20 billion/yr
  2. Via Disease Management 10 billion/yr
  3. Total 30 billion/yr

18
  • Barriers to Functional Foods Contributing to
    Human Health and Chronic Disease Prevention in
    Canada
  • Health Canada does not currently allow any
    health claims on functional foods (labels,
    etc.) regardless of proof of efficacy, safety,
    published human/clinical trials, etc.
    Therapeutic claims are generally restricted to
    patented, costly, imported pharmaceutical (not
    natural) agents/chemicals.
  • Functional Food/Nutraceutical use in health care
    (health, disease prevention/management) not
    generally known by health care professionals
    (e.g., not taught in medical school curricula).

19
  • Medical Research Council (CIHR) spends lt1 of its
    research budget on Functional Food human
    research (incl. product development, other).
    This is a fraction of what is spent on research
    directed at evaluating imported pharmaceuticals
    (drugs).
  • Health coverage (insurance, OHIP, private plans,
    etc.) will not cover nutraceuticals/functional
    foods as therapeutic agents (only drugs) in
    contrast to other countries.
  • Numerous others

20
  1. Diet-related chronic diseases and disorders
    (cardiovascular diseases, type 2 diabetes, many
    cancers, other) are of major and increasing
    prevalence in our population. These contribute
    to our present and accelerating health care
    expenditures with this trend continuing as our
    population ages.
  2. Canadians have been denied access to functional
    foods with natural nutraceutical components for
    the prevention, delay of onset, retardation of
    disease, and disease management (including risk
    factor modification) despite overwhelming
    evidence-based published human studies showing
    their dramatic ability to be highly effective in
    these regards and to dramatically reduce health
    care costs.
  3. The public have indicated their general
    unwillingness to significantly change the
    western-style diet as now consumed. Functional
    foods and nutraceuticals can dramatically reduce
    disease incidence, severity, progression, etc.
    with or without any significant changes in
    overall dietary consumption patterns.

21
  • Health care costs in Canada can be reduced by a
    minimum of 20 billion/yr by early risk factor
    management and the accompanying disease
    prevention /retardation along with an additional
    minimal
  • 10 billion savings for disease management
    applications.
  • The agri-food industry/sector needs extensive
    government support if it intends to be an
    international participant at the forefront of
    producing functional foods for disease prevention
    and management (along with the economic benefits
    to Canada that can be derived from such a
    prioritizing of resources, research, job
    creation, marketing opportunities, use of our
    natural agricultural resources, etc.). The gross
    under-funding of research in the area of
    functional foods for disease prevention in this
    country is in striking contrast to the past and
    previous research allocations given to
    drug-related research (usually on patented
    pharmaceuticals from non-Canadian sources).
    Canada is lagging well behind other countries in
    this important area.

22
  • A preventive model using functional foods and
    not the regular medical model needs to be
    established as soon as possible using a new breed
    of preventive health specialists from our vast
    pool of eager, young, and underemployed B.Sc.
    graduates in life sciences from across Canada.
    The preventive model should focus on early
    detection and functional food-based control of
    moderate risk factors in our younger population
    using the preventive specialists without a
    dependency on physicians.
  • Education and training of various health
    specialists and professionals as well as the
    public in functional foods and natural
    nutraceuticals for the prevention and management
    of disease is also needed.
  • The public, food industry, academic plus
    government scientists, and various health
    specialists/professionals have indicated their
    enthusiastic interest and support for the early
    and broad-based entry of functional foods with
    appropriate health claims into the Canadian
    marketplace. Functional foods need to become the
    pharmacy for disease prevention as well as
    management.
  • Government leadership in launching functional
    foods with natural nutraceutical components is
    desperately needed in Canada as soon as possible.

23
Functional Foods Can Become the Pharmacy for
Disease Prevention
Write a Comment
User Comments (0)
About PowerShow.com